Abstract:Objective: Accumulated studies have revealed that oxidative stress and inflammation play important roles in the development of OSA related cognitive dysfunction. Galectin-3, a member of the galectin family, has been reported to be involved in the neuroinflammatory diseases. However, the relationship between Galectin-3 and cognitive impairment in OSA remains ambiguous. Materials and methods: 47 new diagnosed OSA patients and 18 age-, gender-, education- and body mass index-matched healthy control subjects were enrolled in the present study. All subjects underwent whole-night in-laboratory polysomnography (PSG). Montreal Cognitive Assessment (MoCA) was used to evaluated the cognitive function of OSA patients. Serum Galectin-3, interleukin (IL)-1b and IL-8 were examined by enzyme-linked immunosorbent assay (ELISA). The levels of malonaldehyde (MDA), superoxide dismutase (SOD) and catalase (CAT) were measured to evaluate oxidative stress. Protein level of Galectin-3 and NLRP3 in peripheral blood mononuclear cells (PBMCs) and human microglial clone 3 (HMC3) cells were measured by Western Blot. Results: Serum Galectin-3 level in severe OSA patients (2.31 +/- 0.43 ng/m) was higher than those in mildmoderate OSA patients (1.87 +/- 0.32 ng/m, p < 0.001) and those in the healthy controls (1.56 +/- 0.22 ng/ml, p < 0.001). Similarly, Galectin-3 level in PBMCs was increased with disease severity (p < 0.01). In addition, OSA patients also showed higher levels of inflammation and oxidative stress (p < 0.01). Patients with OSA scored significantly lower than healthy controls on the MoCA test after controlling for age, gender, education, and BMI. CPAP treatment for 12 weeks effectively reduced the levels of Galectin-3, inflammation and oxidative stress, as well as improved cognitive function of severe OSA patients. Closed correlations were observed between Galectin-3 with sleep respiratory parameters and cognitive dysfunction. In addition, we explored the underlying mechanism of Galectin-3 in neuroinflammation and oxidative stress. We treated HMC3 cells with LPS to mimic neuroinflammatory response in vitro. The results showed that LPS treatment led to a dose-dependent increase in Galectin-3 expression, meanwhile induced inflammation and oxidative stress. Inhibiting Galectin-3 with a specific Galectin-3 inhibitor, TD139, significantly ameliorated LPS-induced neuroinflammation and oxidative stress via suppressing NLRP3. Conclusion: Current findings suggest that increased Galectin-3 might be involved in the cognitive impairment of OSA patients by promoting neuroinflammation and oxidative stress via regulating NLRP3. These results suggested that Galectin-3 inhibition may exert a protective role against the neurocognitive dysfunction associated with OSA.

NLRP3/miR-223-3p axis attenuates neuroinflammation induced by chronic intermittent hypoxia

NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea

The NLRP3 Inflammasome is Involved in Resident Intruder Paradigm-Induced Aggressive Behaviors in Mice

NLRP3 Inﬂammasome Mediates Chronic Intermittent Hypoxia‐induced Renal Injury Implication of the Microrna‐155/foxo3a Signaling Pathway

Increased Oxidative Stress is Associated with Chronic Intermittent Hypoxia-Mediated Brain Cortical Neuronal Cell Apoptosis in a Mouse Model of Sleep Apnea

NLRP3 inflammasome regulates astrocyte transformation in brain injury induced by chronic intermittent hypoxia

Pinocembrin Ameliorates Intermittent Hypoxia-induced Neuroinflammation Through BNIP3-dependent Mitophagy in a Murine Model of Sleep Apnea

NLRP3 Inflammasome Triggers Inflammation of Obstructive Sleep Apnea

Blocking the LncRNA MALAT1/miR-224-5p/NLRP3 Axis Inhibits the Hippocampal Inflammatory Response in T2DM With OSA

NLRP3 inflammasome activation mediates sleep deprivation-induced pyroptosis in mice

CIH-induced Neurocognitive Impairments Are Associated with Hippocampal Ca2+ Overload, Apoptosis, and Dephosphorylation of ERK1/2 and CREB That Are Mediated by Overactivation of NMDARs

Involvement of Galectin-3 in Neurocognitive Impairment in Obstructive Sleep Apnea Via Regulating Inflammation and Oxidative Stress Through NLRP3.

Overexpression of MiR-188-5p Downregulates IL6ST/STAT3/ NLRP3 Pathway to Ameliorate Neuron Injury in Oxygen-glucose Deprivation/Reoxygenation

LncRNA xist regulates sepsis associated neuroinflammation in the periventricular white matter of CLP rats by miR-122-5p/PKCη Axis

ω3-PUFA alleviates neuroinflammation by upregulating miR-107 targeting PIEZO1/NFκB p65

SENP1 Regulates Intermittent Hypoxia-Induced Microglia Mediated Inflammation and Cognitive Dysfunction Via Wnt/β-catenin Pathway

NLRP3 Deficiency Protects Against Hypobaric Hypoxia Induced Neuroinflammation and Cognitive Dysfunction

The Potential Role of the NLRP3 Inflammasome Activation as a Link Between Mitochondria ROS Generation and Neuroinflammation in Postoperative Cognitive Dysfunction

Upregulation of miRNA-223-3p ameliorates RIP3-mediated necroptosis and inflammatory responses via targeting RIP3 after spinal cord injury.

Combined exposure to lead and high-fat diet induced neuronal deficits in rats: Anti-neuroinflammatory role of SIRT1

The relationship between inflammation and neurocognitive dysfunction in obstructive sleep apnea syndrome